6-aminonicotinamide has been researched along with Viremia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, XF; Chen, J; Cheng, ST; Hu, JL; Hu, ZW; Huang, AL; Jia, XJ; Jiang, H; Law, BYK; Ren, F; Ren, JH; Wong, VKW; Xu, HY; Yang, X; Yao, FL; Yu, HB; Zhang, WL; Zhong, S; Zhou, HZ | 1 |
1 other study(ies) available for 6-aminonicotinamide and Viremia
| Article | Year |
|---|---|
Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.
Topics: 6-Aminonicotinamide; Animals; Biomarkers; Disease Models, Animal; Hep G2 Cells; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Promoter Regions, Genetic; Transcription, Genetic; Viremia; Virus Replication | 2019 |